418 related articles for article (PubMed ID: 17059824)
1. Fine and domain-level epitope mapping of botulinum neurotoxin type A neutralizing antibodies by yeast surface display.
Levy R; Forsyth CM; LaPorte SL; Geren IN; Smith LA; Marks JD
J Mol Biol; 2007 Jan; 365(1):196-210. PubMed ID: 17059824
[TBL] [Abstract][Full Text] [Related]
2. Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization.
Smith TJ; Lou J; Geren IN; Forsyth CM; Tsai R; Laporte SL; Tepp WH; Bradshaw M; Johnson EA; Smith LA; Marks JD
Infect Immun; 2005 Sep; 73(9):5450-7. PubMed ID: 16113261
[TBL] [Abstract][Full Text] [Related]
3. Immunological Characterization and Neutralizing Ability of Monoclonal Antibodies Directed Against Botulinum Neurotoxin Type H.
Fan Y; Barash JR; Lou J; Conrad F; Marks JD; Arnon SS
J Infect Dis; 2016 May; 213(10):1606-14. PubMed ID: 26936913
[TBL] [Abstract][Full Text] [Related]
4. Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin.
Garcia-Rodriguez C; Geren IN; Lou J; Conrad F; Forsyth C; Wen W; Chakraborti S; Zao H; Manzanarez G; Smith TJ; Brown J; Tepp WH; Liu N; Wijesuriya S; Tomic MT; Johnson EA; Smith LA; Marks JD
Protein Eng Des Sel; 2011 Mar; 24(3):321-31. PubMed ID: 21149386
[TBL] [Abstract][Full Text] [Related]
5. Fully Human Monoclonal Antibodies Effectively Neutralizing Botulinum Neurotoxin Serotype B.
Matsumura T; Amatsu S; Misaki R; Yutani M; Du A; Kohda T; Fujiyama K; Ikuta K; Fujinaga Y
Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32392791
[TBL] [Abstract][Full Text] [Related]
6. A three monoclonal antibody combination potently neutralizes multiple botulinum neurotoxin serotype F subtypes.
Fan Y; Garcia-Rodriguez C; Lou J; Wen W; Conrad F; Zhai W; Smith TJ; Smith LA; Marks JD
PLoS One; 2017; 12(3):e0174187. PubMed ID: 28323873
[TBL] [Abstract][Full Text] [Related]
7. Epitope characterization of sero-specific monoclonal antibody to Clostridium botulinum neurotoxin type A.
Corbett CR; Ballegeer E; Weedmark KA; Elias MD; Al-Saleem FH; Ancharski DM; Simpson LL; Berry JD
Hybridoma (Larchmt); 2011 Dec; 30(6):503-10. PubMed ID: 22149274
[TBL] [Abstract][Full Text] [Related]
8. Genetic and immunological comparison of anti-botulinum type A antibodies from immune and non-immune human phage libraries.
Amersdorfer P; Wong C; Smith T; Chen S; Deshpande S; Sheridan R; Marks JD
Vaccine; 2002 Feb; 20(11-12):1640-8. PubMed ID: 11858873
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the monoclonal antibody response to botulinum neurotoxin type A in the complexed and uncomplexed forms.
Zhao H; Nakamura K; Kohda T; Mukamoto M; Kozaki S
Jpn J Infect Dis; 2012; 65(2):138-45. PubMed ID: 22446121
[TBL] [Abstract][Full Text] [Related]
10. Neutralizing antibodies of botulinum neurotoxin serotype A screened from a fully synthetic human antibody phage display library.
Yu R; Wang S; Yu YZ; Du WS; Yang F; Yu WY; Sun ZW
J Biomol Screen; 2009 Sep; 14(8):991-8. PubMed ID: 19726786
[TBL] [Abstract][Full Text] [Related]
11. Epitope mapping of neutralizing botulinum neurotoxin A antibodies by phage display.
Mullaney BP; Pallavicini MG; Marks JD
Infect Immun; 2001 Oct; 69(10):6511-4. PubMed ID: 11553596
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a highly neutralizing single monoclonal antibody to botulinum neurotoxin type A.
Brier S; Rasetti-Escargueil C; Wijkhuisen A; Simon S; Marechal M; Lemichez E; Popoff MR
FASEB J; 2021 May; 35(5):e21540. PubMed ID: 33817838
[TBL] [Abstract][Full Text] [Related]
13. Potent neutralization of botulinum neurotoxin/B by synergistic action of antibodies recognizing protein and ganglioside receptor binding domain.
Chen C; Wang S; Wang H; Mao X; Zhang T; Ji G; Shi X; Xia T; Lu W; Zhang D; Dai J; Guo Y
PLoS One; 2012; 7(8):e43845. PubMed ID: 22952786
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal Antibodies that Inhibit the Proteolytic Activity of Botulinum Neurotoxin Serotype/B.
Fan Y; Dong J; Lou J; Wen W; Conrad F; Geren IN; Garcia-Rodriguez C; Smith TJ; Smith LA; Ho M; Pires-Alves M; Wilson BA; Marks JD
Toxins (Basel); 2015 Aug; 7(9):3405-23. PubMed ID: 26343720
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of enhanced neutralization of botulinum neurotoxin by monoclonal antibodies conjugated to antibodies specific for the erythrocyte complement receptor.
Sharma R; Zhao H; Al-Saleem FH; Ubaid AS; Puligedda RD; Segan AT; Lindorfer MA; Bermudez R; Elias M; Adekar SP; Simpson LL; Taylor RP; Dessain SK
Mol Immunol; 2014 Feb; 57(2):247-54. PubMed ID: 24184879
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the antibody response to the receptor binding domain of botulinum neurotoxin serotypes A and E.
Baldwin MR; Tepp WH; Pier CL; Bradshaw M; Ho M; Wilson BA; Fritz RB; Johnson EA; Barbieri JT
Infect Immun; 2005 Oct; 73(10):6998-7005. PubMed ID: 16177380
[TBL] [Abstract][Full Text] [Related]
17. Epitope characterization and variable region sequence of f1-40, a high-affinity monoclonal antibody to botulinum neurotoxin type a (Hall strain).
Scotcher MC; McGarvey JA; Johnson EA; Stanker LH
PLoS One; 2009; 4(3):e4924. PubMed ID: 19290051
[TBL] [Abstract][Full Text] [Related]
18. Mapping of the antibody-binding regions on the HN-domain (residues 449-859) of botulinum neurotoxin A with antitoxin antibodies from four host species. Full profile of the continuous antigenic regions of the H-chain of botulinum neurotoxin A.
Atassi MZ; Dolimbek BZ
Protein J; 2004 Jan; 23(1):39-52. PubMed ID: 15115181
[TBL] [Abstract][Full Text] [Related]
19. Development of neutralizing scFv-Fc against botulinum neurotoxin A light chain from a macaque immune library.
Miethe S; Rasetti-Escargueil C; Liu Y; Chahboun S; Pelat T; Avril A; Frenzel A; Schirrmann T; Thullier P; Sesardic D; Hust M
MAbs; 2014; 6(2):446-59. PubMed ID: 24492304
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal Antibodies Targeting the Alpha-Exosite of Botulinum Neurotoxin Serotype/A Inhibit Catalytic Activity.
Fan Y; Geren IN; Dong J; Lou J; Wen W; Conrad F; Smith TJ; Smith LA; Ho M; Pires-Alves M; Wilson BA; Marks JD
PLoS One; 2015; 10(8):e0135306. PubMed ID: 26275214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
